Hexagon Capital Partners’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-1,791
| Closed | -$14.3K | – | 1547 |
|
2025
Q1 | $14.3K | Sell |
1,791
-247
| -12% | -$1.97K | ﹤0.01% | 864 |
|
2024
Q4 | $18.5K | Buy |
2,038
+27
| +1% | +$245 | ﹤0.01% | 814 |
|
2024
Q3 | $18.5K | Sell |
2,011
-60
| -3% | -$551 | ﹤0.01% | 742 |
|
2024
Q2 | $20.3K | Buy |
2,071
+838
| +68% | +$8.2K | ﹤0.01% | 684 |
|
2024
Q1 | $18.6K | Sell |
1,233
-353
| -22% | -$5.33K | ﹤0.01% | 694 |
|
2023
Q4 | $34.2K | Buy |
1,586
+1,065
| +204% | +$23K | 0.01% | 500 |
|
2023
Q3 | $9.69K | Buy |
521
+59
| +13% | +$1.1K | ﹤0.01% | 757 |
|
2023
Q2 | $11.7K | Buy |
462
+244
| +112% | +$6.18K | ﹤0.01% | 706 |
|
2023
Q1 | $5.65K | Buy |
218
+11
| +5% | +$285 | ﹤0.01% | 869 |
|
2022
Q4 | $4.9K | Hold |
207
| – | – | ﹤0.01% | 924 |
|
2022
Q3 | $5K | Buy |
207
+190
| +1,118% | +$4.59K | ﹤0.01% | 942 |
|
2022
Q2 | $1K | Hold |
17
| – | – | ﹤0.01% | 1129 |
|
2022
Q1 | $1K | Hold |
17
| – | – | ﹤0.01% | 888 |
|
2021
Q4 | $2K | Hold |
17
| – | – | ﹤0.01% | 778 |
|
2021
Q3 | $2K | Hold |
17
| – | – | ﹤0.01% | 783 |
|
2021
Q2 | $3K | Buy |
17
+7
| +70% | +$1.24K | ﹤0.01% | 700 |
|
2021
Q1 | $1K | Sell |
10
-366
| -97% | -$36.6K | ﹤0.01% | 725 |
|
2020
Q4 | $75K | Buy |
376
+300
| +395% | +$59.8K | 0.02% | 227 |
|
2020
Q3 | $14K | Buy |
+76
| New | +$14K | ﹤0.01% | 416 |
|